Bridgepoint Group (LON:BPT) Price Target Raised to GBX 395

Key Points

• Citigroup raised its price target for Bridgepoint Group (LON:BPT) from GBX 360 to GBX 395, maintaining a "buy" rating, indicating a potential upside of 14.98% based on the current price.
• Other analysts, including Deutsche Bank and JPMorgan Chase, have differing price targets for Bridgepoint Group, with Deutsche Bank at GBX 345 and JPMorgan at GBX 424.
• Bridgepoint Group operates as a private equity and credit firm, focusing on various sectors such as healthcare, digital brands, and energy transition enablers.

Bridgepoint Group (LON:BPT - Get Free Report) had its price objective increased by stock analysts at Citigroup from GBX 360 ($4.81) to GBX 395 ($5.28) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage presently has a "buy" rating on the stock. Citigroup's target price suggests a potential upside of 14.98% from the company's current price.

A number of other equities research analysts have also issued reports on BPT. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 345 ($4.61) price target on shares of Bridgepoint Group in a research report on Monday, July 21st. JPMorgan Chase & Co. reaffirmed an "overweight" rating and issued a GBX 424 ($5.66) price target on shares of Bridgepoint Group in a research report on Thursday.

Bridgepoint Group Price Performance

BPT stock opened at GBX 343.54 ($4.59) on Thursday. The company has a debt-to-equity ratio of 12.89, a current ratio of 4.98 and a quick ratio of 3.60. The firm has a market capitalization of £2.84 billion, a P/E ratio of 62.41, a P/E/G ratio of 0.61 and a beta of 1.72. The business's 50-day moving average is GBX 311.89 and its two-hundred day moving average is GBX 315.47. Bridgepoint Group has a 1 year low of GBX 229.20 ($3.06) and a 1 year high of GBX 410 ($5.48).

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.